From Endless Assay Components to One Integrated Solution: A Case Study with CardioPath Laboratories

CardioPath Laboratories logo

CardioPath Laboratories is a US-based comprehensive laboratory providing histology, immunohistochemistry, and molecular testing via endomyocardial biopsy using a simple, all-in-one approach. CardioPath also performs COVID-19 testing with a high-throughput capacity of 1,000 patient samples per day. CardioPath is registered as a CLIA (Clinical Laboratory Improvement Amendments) and College of American Pathologists (CAP)-accredited high complexity lab. […]

The Rapid Evolution of Seegene’s COVID-19 Solutions

It’s been one year since Seegene produced a complete respiratory diagnostic test that has taken the uncertainty out of differentiating COVID-19 infection from other respiratory illnesses Fast Response In January 2020, before a single patient with SARS-CoV-2 virus had been identified in South Korea, molecular diagnostic company Seegene leveraged its proven automated assay development platform […]

The Future of Diagnostics: Syndromic Assays

How High Multiplex assays that test for many common pathogens at once can accelerate diagnostics and facilitate a higher quality of care When a patient presents with a symptom, many pathogens could be at fault. Standard clinical practice is to take a sample from the patient and perform a diagnostic test or tests for suspected […]